Clinical Trials in Miami

Showing 2941-2960 of 9,821 trials

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

NCT04401020

Primary Objective: To determine the maximum tolerated dose (MTD) of SAR442257 administered as a single agent in patients with relapsed and refractory multiple myeloma (RRMM) and relapsed and refractory non-Hodgkin lymphoma (RR-NHL), and determine the recommended Phase 2 dose (RP2D) Secondary Objectives: * To characterize the safety profile of SAR442257 * To characterize the pharmacokinetics (PK) profile of SAR442257 * To assess preliminary evidence of antitumor activity

Neoplasm Malignant

Sanofi47 participantsStarted Jul 2020

Duarte, California, United States • Miami, Florida, United States • Rochester, Minnesota, United States +13 more locations

TERMINATEDPhase 2< 1 mile

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

NCT04778410

The goal of this clinical study is to learn more about the safety and dosing of the study drug, magrolimab (Mag), in combination with anti-leukemia therapies in participants with acute myeloid leukemia (AML).

Myeloid Malignancies

Gilead Sciences54 participantsStarted Jun 2021

Birmingham, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +18 more locations

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Find Trials by Condition in Miami

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

NOVOCART®3D for Treatment of Articular Cartilage of the Knee

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

A Study of JR-171 in Patients With Mucopolysaccharidosis I